Related Experiment Video
Updated: May 18, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
Christy Goldsmith1, Andrew Gaya
1CyberKnife Centre, The Harley Street Clinic, London, UK. christy.goldsmith@hcahealthcare.co.uk
Abstract:
Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment of primary and secondary lung tumours is appraised, and key ongoing trials are identified.

